Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
Learn more: QUEEN’S SCIENTISTS DEVELOP NEW TREATMENT TO PROLONG LIFE OF THOSE WITH CYSTIC FIBROSIS
The Latest on: Cystic Fibrosis
[google_news title=”” keyword=”Cystic Fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cystic Fibrosis
- Woman from Palm Beach found guilty of defrauding Cystic Fibrosis nonprofiton February 6, 2023 at 3:45 pm
A Federal jury convicted a woman out of Palm Beach for defrauding a Cystic Fibrosis nonprofit. According to the Department of Justice, 34-year-old Elizabeth Genna Suarez, formerly known as Elizabeth ...
- In virtuous cycle, foundation uses drug royalty riches to back new cystic fibrosis drug research in Bay Areaon February 6, 2023 at 1:34 pm
How startups and public companies are tackling cystic fibrosis with the help of a unique 'venture philanthropy' effort $VRTX $ARDS $FDMT ...
- What It’s Like to Learn You’re Going to Live Longer Than You Expectedon February 6, 2023 at 2:01 am
And thanks to a new drug that has revolutionized the treatment of this disease, she will likely live to celebrate her 40th and even 50th birthdays. Her life expectancy has shifted drastically within ...
- Florida woman convicted for stealing thousands of dollars meant for cystic fibrosis patientson February 5, 2023 at 10:06 am
A Florida woman was convicted last week for stealing thousands of dollars meant for cystic fibrosis patients to get cosmetic procedures.
- How CF Taught Me To Appreciate Lifeon February 3, 2023 at 2:30 am
Having cystic fibrosis has been a double-edged sword. CF has caused suffering, but it also has given me the perspective to embrace my life.
- Non-Cystic Fibrosis Bronchiectasis Market 2023 : Research Report, Industry Growth, Competitors Analysis and Forecast 2028on February 2, 2023 at 8:04 pm
Feb 02, 2023 (The Expresswire) -- Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Non-Cystic Fibrosis Bronchiectasis industry. This research report provides ...
- Ex-FL Firefighter Convicted of Taking Cystic Fibrosis Charity Fundson February 2, 2023 at 6:34 am
Elizabeth Genna Suarez, 34, was convicted by a federal jury on three of four counts of misappropriating $158,960 from a fund for people with cystic fibrosis, WFIX reported. Suarez was a Palm Beach ...
- First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosison February 2, 2023 at 4:00 am
Patient dosing expected to begin in mid-February with topline data anticipated by mid-2023BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), ...
- Ex-Palm Beach County firefighter guilty of stealing nearly $159,000 from cystic fibrosis charityon February 2, 2023 at 3:00 am
A federal jury convicted a former Palm Beach County firefighter on three counts of misappropriating $158,960 from Piper's Angels Foundation Inc., which provides support to people with cystic fibrosis.
- Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.on January 29, 2023 at 10:04 pm
Individuals with diabetes mellitus (DM) are known to frequently experience gastrointestinal (GI) symptoms. In contrast, the impact of cystic fibrosis-related diabetes (CFRD) on accentuating GI ...
via Bing News